GYRE Insider Transactions — Page 4
563 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 301–400; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| BVF INC/IL | TenPercentOwner | 2012-10-31 | Purchase | 46,700.0 | $4.06 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2012-10-31 | Purchase | 46,700.0 | $4.06 |
| LAMPERT MARK N | TenPercentOwner | 2012-10-31 | Purchase | 46,700.0 | $4.06 |
| Richard John P | Director | 2012-06-08 | Purchase | 7,500.0 | $4.16 |
| Richard John P | Director | 2011-07-01 | Sale | 2,500.0 | $21.02 |
| Musso Alan A | SVP, CFO & Treasurer | 2011-06-07 | Sale | 30,875.0 | $21.8 |
| BROWN JULIA R | Director | 2011-05-13 | Sale | 9,100.0 | $23.38 |
| BURRILL STEVEN | Director | 2011-05-12 | Sale | 33,052.0 | $23.88 |
| BURRILL STEVEN | Director | 2011-05-11 | Sale | 33,052.0 | $23.88 |
| BURRILL STEVEN | Director | 2011-05-10 | Sale | 2,000.0 | $24.13 |
| BURRILL STEVEN | Director | 2011-05-10 | Sale | 16,948.0 | $24.04 |
| BURRILL STEVEN | Director | 2011-05-10 | Sale | 2,000.0 | $24.13 |
| BURRILL STEVEN | Director | 2011-05-10 | Sale | 16,948.0 | $24.04 |
| Richard John P | Director | 2011-04-01 | Sale | 2,500.0 | $26.6 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2011-03-31 | Sale | 2,655.0 | $26.37 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 2011-03-09 | Sale | 1,500.0 | $30.0 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 2011-03-07 | Sale | 500.0 | $30.0 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 2011-03-03 | Sale | 5,030.0 | $30.0 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 2011-03-02 | Sale | 200.0 | $30.0 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 2011-03-01 | Sale | 12,703.0 | $30.16 |
| Brennan Jeffrey P | SVP - Bus. & Commercial Dev. | 2011-03-01 | Sale | 1,264.0 | $30.0 |
| Hicks Karen A | VP Human Resources | 2011-03-01 | Sale | 1,243.0 | $30.0 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2011-03-01 | Sale | 11,360.0 | $30.0 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2011-02-28 | Sale | 15,481.0 | $28.0 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2011-02-16 | Sale | 16,655.0 | $26.52 |
| Richard John P | Director | 2011-01-19 | Sale | 5,000.0 | $27.11 |
| Bencherif Merouane | SVP, Preclinical Research | 2011-01-19 | Sale | 30,203.0 | $27.09 |
| Richard John P | Director | 2011-01-18 | Sale | 2,500.0 | $27.38 |
| Bencherif Merouane | SVP, Preclinical Research | 2011-01-18 | Sale | 22,800.0 | $27.17 |
| Hicks Karen A | VP Human Resources | 2011-01-14 | Sale | 1,719.0 | $27.5 |
| Hicks Karen A | VP Human Resources | 2011-01-13 | Sale | 3,369.0 | $27.24 |
| Hicks Karen A | VP Human Resources | 2011-01-12 | Sale | 11,231.0 | $27.18 |
| Hicks Karen A | VP Human Resources | 2011-01-11 | Sale | 13,825.0 | $27.02 |
| Musso Alan A | SVP, CFO & Treasurer | 2010-12-22 | Sale | 4,881.0 | $26.47 |
| Musso Alan A | SVP, CFO & Treasurer | 2010-12-21 | Sale | 15,535.0 | $26.61 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 2010-12-20 | Sale | 8,882.0 | $26.02 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 2010-12-17 | Sale | 2,100.0 | $26.08 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 2010-12-16 | Sale | 2,700.0 | $25.24 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 2010-12-16 | Sale | 200.0 | $25.15 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2010-12-13 | Sale | 12,000.0 | $23.95 |
| Brennan Jeffrey P | SVP - Bus. & Commercial Dev. | 2010-12-13 | Sale | 10,000.0 | $23.86 |
| Bencherif Merouane | SVP, Preclinical Research | 2010-12-10 | Sale | 32,093.0 | $24.05 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 2010-12-08 | Sale | 11,250.0 | $22.68 |
| SKALETSKY MARK B | Director | 2010-11-17 | Sale | 29,500.0 | $22.0 |
| BLIXT CHARLES A | Director | 2010-11-17 | Sale | 5,500.0 | $21.76 |
| SKALETSKY MARK B | Director | 2010-11-16 | Sale | 3,000.0 | $21.76 |
| BLIXT CHARLES A | Director | 2010-11-16 | Sale | 9,500.0 | $21.8 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 2010-11-05 | Sale | 700.0 | $25.02 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 2010-11-05 | Sale | 1,400.0 | $25.01 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 2010-11-04 | Sale | 7,784.0 | $25.07 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 2010-11-04 | Sale | 7,800.0 | $25.08 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 2010-11-03 | Sale | 986.0 | $25.05 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 2010-11-03 | Sale | 1,000.0 | $25.06 |
| Musso Alan A | SVP, CFO & Treasurer | 2010-10-28 | Sale | 1,500.0 | $24.6 |
| Musso Alan A | SVP, CFO & Treasurer | 2010-10-26 | Sale | 2,000.0 | $24.65 |
| Musso Alan A | SVP, CFO & Treasurer | 2010-10-25 | Sale | 8,500.0 | $24.69 |
| Musso Alan A | SVP, CFO & Treasurer | 2010-10-22 | Sale | 600.0 | $24.6 |
| DUNTON ALAN W | Director | 2010-08-02 | Sale | 6,000.0 | $22.3 |
| DUNTON ALAN W | Director | 2010-07-26 | Sale | 2,864.0 | $21.12 |
| DUNTON ALAN W | Director | 2010-07-23 | Sale | 2,336.0 | $21.0 |
| DUNTON ALAN W | Director | 2010-07-15 | Sale | 6,800.0 | $20.72 |
| BROWN JULIA R | Director | 2010-05-21 | Sale | 7,307.0 | $23.13 |
| BROWN JULIA R | Director | 2010-05-20 | Sale | 5,193.0 | $22.97 |
| Musso Alan A | SVP, CFO & Treasurer | 2010-05-18 | Sale | 3,424.0 | $24.7 |
| Musso Alan A | SVP, CFO & Treasurer | 2010-05-17 | Sale | 382.0 | $24.6 |
| Musso Alan A | SVP, CFO & Treasurer | 2010-05-17 | Sale | 8,400.0 | $24.21 |
| Richard John P | Director | 2010-05-14 | Sale | 8,500.0 | $24.22 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 2010-05-13 | Sale | 1,494.0 | $25.0 |
| Hicks Karen A | VP Human Resources | 2010-05-13 | Sale | 1,469.0 | $25.0 |
| Hodges Mauri K | VP Finance & Controller | 2010-05-13 | Sale | 1,402.0 | $25.0 |
| Hicks Karen A | VP Human Resources | 2010-05-13 | Sale | 4,226.0 | $24.1 |
| BROWN JULIA R | Director | 2010-05-12 | Sale | 7,500.0 | $23.05 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2010-05-03 | Sale | 17,000.0 | $24.29 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2010-04-30 | Sale | 15,263.0 | $24.27 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2010-04-29 | Sale | 35,100.0 | $24.18 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2010-04-28 | Sale | 16,000.0 | $24.0 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 2010-04-28 | Sale | 14,700.0 | $24.0 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 2010-04-27 | Sale | 200.0 | $24.0 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2010-04-27 | Sale | 315.0 | $24.0 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 2010-04-26 | Sale | 257.0 | $24.0 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2010-04-26 | Sale | 600.0 | $24.0 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2010-04-20 | Sale | 15,900.0 | $23.0 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2010-04-19 | Sale | 100.0 | $23.0 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 2010-04-16 | Sale | 36,946.0 | $23.02 |
| Zorn Peter A | SVP, Lg Affrs, GC and Secrtary | 2010-03-31 | Sale | 313.0 | $19.41 |
| SNYDERMAN RALPH | Director | 2010-02-16 | Sale | 15,000.0 | $19.92 |
| Bencherif Merouane | VP, Preclinical Research | 2010-01-15 | Sale | 73,108.0 | $20.51 |
| Bencherif Merouane | VP, Preclinical Research | 2010-01-04 | Sale | 7,735.0 | $20.81 |
| Zorn Peter A | VP, Lg Affrs, GC and Secrtary | 2009-12-31 | Sale | 4,092.0 | $21.02 |
| Zorn Peter A | VP, Lg Affrs, GC and Secrtary | 2009-12-31 | Sale | 312.0 | $21.3 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-12-16 | Sale | 23,206.0 | $21.93 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-12-16 | Sale | 23,201.0 | $21.93 |
| deBethizy J Donald | President and CEO | 2009-12-16 | Sale | 209,004.0 | $21.98 |
| deBethizy J Donald | President and CEO | 2009-12-16 | Sale | 630.0 | $22.99 |
| deBethizy J Donald | President and CEO | 2009-12-16 | Sale | 28,296.0 | $22.0 |
| Bencherif Merouane | VP, Preclinical Research | 2009-12-16 | Sale | 15,532.0 | $21.93 |
| Dunbar Geoffrey C | VP, Clin. Dev. & Reg. Affairs | 2009-12-16 | Sale | 22,602.0 | $21.86 |
| Musso Alan A | VP, CFO & Treasurer | 2009-12-16 | Sale | 1,000.0 | $22.27 |
| Musso Alan A | VP, CFO & Treasurer | 2009-12-15 | Sale | 11,809.0 | $22.31 |
| Bencherif Merouane | VP, Preclinical Research | 2009-12-15 | Sale | 8,056.0 | $22.19 |